[1]朱峰 徐宁 葛腾飞 汤磊 王路 刘丹 马冬春**.同期双侧单孔胸腔镜手术治疗胸腺瘤合并重症肌无力[J].中国微创外科杂志,2020,01(2):125-127.
　Zhu Feng,Xu Ning,Ge Tengfei,et al.Bilateral Uniportal Thoracoscopic Surgery for Thymoma With Myasthenia Gravis[J].Chinese Journal of Minimally Invasive Surgery,2020,01(2):125-127.
点击复制

同期双侧单孔胸腔镜手术治疗胸腺瘤合并重症肌无力()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2020年2期
页码:
125-127
栏目:
临床研究
出版日期:
2020-02-28

文章信息/Info

Title:
Bilateral Uniportal Thoracoscopic Surgery for Thymoma With Myasthenia Gravis
作者:
朱峰 徐宁 葛腾飞 汤磊 王路 刘丹 马冬春**
（安徽省胸科医院胸外三科，合肥230022）
Author(s):
Zhu Feng;  Xu Ning;  Ge Tengfei;  et al.
Department of Thoracic Surgery, Anhui Chest Hospital, Hefei 230022, China
关键词:
胸腺瘤;  重症肌无力; 单孔胸腔镜手术
Keywords:
Thymoma; Myasthenia gravis; Uniportal thoracoscopic surgery
文献标志码:
A
摘要:
目的探讨同期双侧单孔胸腔镜下胸腺扩大切除术的可行性及早期手术效果。方法2017年8月~2019年6月，对20例胸腺瘤合并重症肌无力行同期双侧单孔胸腔镜下胸腺扩大切除术。切口位于腋前线和腋中线之间第4肋间，长3 cm。结果手术均顺利完成，手术时间(183.2±27.8)min，术中失血量(36.0±27.2)ml，胸腔引流时间(3.9±1.1)d，术后住院时间（6.1±1.4)d，病理测量瘤体最大径（4.3±1.3）cm。无围手术期并发症。Masaoka分期Ⅰ期2例，Ⅱ期16例，Ⅲ期2例（B2型和B3型各1例）。20例随访2~24个月，中位数14个月，总体缓解率90%（18/20）。结论同期双侧单孔胸腔镜下胸腺扩大切除术治疗胸腺瘤合并重症肌无力，手术安全，近期效果满意。
Abstract:
ObjectiveTo evaluate the feasibility of bilateral uniportal thoracoscopic extended thymectomy and early clinical results of this technique.MethodsTwenty patients with myasthenia gravis with thymoma underwent bilateral uniportal thoracoscopic extended thymectomy from August 2017 to June 2019. The incision was 3 cm in lenth and located at the 4th intercostal space between the anterior axillary line and the midaxillary line.ResultsThe operation was successfully completed, the mean operative time was (183.2±27.8) min, the average blood loss was (36.0±27.2) ml, the chest tube duration was (3.9±1.1) days, the postoperative hospital stay was (6.1±1.4) days, and the tumor size measured by pathology was (4.3±1.3) cm. There were no operative deaths or perioperative complications. There were Masaoka stage Ⅰ in 2 cases, Ⅱ in 16 cases, and Ⅲ in 2 cases (B2 in 1 case and B3 in 1 case). Twenty patients were followed up for 2-24 months, with a median of 14 months. The overall remission rate was 90%(18/20).ConclusionBilateral uniportal thoracoscopic extended thymectomy for thymoma with myasthenia gravis is a safe and promising technique with regard to shortterm clinical outcome.

参考文献/References:

[1]Aramini B,Fan J.Techique for myasthenia gravis:subxiphoid approach.Thrac Surg Clin,2019,29(2):195-202.
[2]胡盛寿.心胸外科学.北京:人民军医出版社,2014.478-483.
[3]BerrihAknin S.Role of the thymus in autoimmune myasthenia gravis.J Neuroimmunol,2016,7(3):226-237．
[4]王伟,刘大仲,徐昊,等.胸腺瘤合并重症肌无力双侧胸腔镜胸腺扩大切除术.中华胸心血管外科杂志,2017,33(3):135-136.
[5]Zieliński M.Surgical approaches to myasthenia gravis perspective of anatomy and radicality in surgery.Thrac Surg Clin,2019,29(2):159-164.
[6]Zielinskia M,Czajkowskia W,Gwozdz P,et a1.Resection of thymomas with use of the Dew minimallyinvasive technique of extended thymectomy performed through the subxiphoidright videothoracoscopic approach with doable elevation of the sternum.Eur J Cardiothorac Surg,2013,44:e113-e119．
[7]Huang P,Ye B,Yang Y,et al.Experience with the “da Vinci” robotic system for earlystage thymomas:report of 23 cases.Thorac Cancer,2014,5(4):325-329．
[8]汪昉睿,庞烈文,傅剑华,等.合并重症肌无力的胸腺瘤患者术后生存的初步分析:ChART数据库回顾性结果.中国肺癌杂志,2016,19(7):418-424.
[9]张云峰,于磊,景筠,等.合并重症肌无力的胸腺瘤治疗与预后特点分析.中华外科杂志,2015,53(8):612-615.
[10]李晓,惠本刚,肖蓉心,等.胸腔镜治疗胸腺瘤的安全性及中长期疗效分析.中国微创外科杂志,2017,17(3):193-196.

备注/Memo

备注/Memo:
基金项目：安徽省卫计委医学科学研究计划项目（15tb006）**通讯作者，Email：madongchun126@126.com
更新日期/Last Update: 2020-05-16